Neuroprotective Effect of Acteoside Against MPTP-induced Mouse Model of Parkinsons Disease

ZHAO Lei,PU Xiao-ping

DOI: https://doi.org/10.3321/j.issn:1001-1978.2007.01.012

2007-01-01

Abstract:Aim To study the neuroprotective effect of Acteoside against MPTP-induced mouse model of Parkinsons disease (PD) and its mechanism. Methods The behavioral testing of C57 mice was assessed using spontaneous movement and rotarod test. DA levels in striatum were measured using HPLC-EC. Dopaminergic neurons in the substantia nigra were observed by immunohistochemical staining with an anti-Tyroxine hydroxylase (TH) antibody. Moreover, the mechanism of the neuroprotective effect of acteoside was investigated using Western blot analysis with an anti-α-synuclein antibody in the substantia nigra and striatum. Results ① Compared with control, MPTP lesion significantly reduced the number of spontaneous movement and latent period of mice on the rotating rod (both P0.01 and DA levels in the striatum (P0.01 ). Also there were less TH-immunoreactive signals in the substantia nigra, and α-synuclein levels in the substantia nigra and striatum were markedly decreased in MPTP-lesioned C57 mice. ② Compared with MPTP model group, the number of spontaneous movement and latent period of mice on the rotating rod were significantly increased (both P0.01) and DA levels in striatum raised (P0.05 and P0.01 respectively) in acteoside-pretreated groups. Moreover, there were more TH-positive signals in the substantia nigra, and α-synuclein levels in the substantia nigra and striatum were significantly increased in MPTP-lesioned C57 mice pretreated with acteoside (30 mg·kg~ -1 ). Conclusions Acteoside may be able to protect C57 mice against MPTP-induced neuronal damage. The neuroprotective effect might be associated with the up-regulation of α-synuclein level.